Navigation Links
Pulmo BioTech Inc. Completes Bio-Distribution Studies
Date:7/7/2008

NEW YORK, July 7 /PRNewswire-FirstCall/ -- Pulmo BioTech Inc. (OTC Bulletin Board: PLMO.OB) has announced that its subsidiary, PulmoScience Inc. has completed the bio-distribution studies on its DFH-12 product candidate for the PulmoBind technology of Molecular Imaging of the vascular system of the lungs.

Molecular Imaging uses a molecule designed to bond specifically to certain parts of the body. In the case of PulmoBind, the chosen molecule was designed to bond only to the inner walls of the vascular system of the lungs. Because the molecule (code named DFH-12) is tagged with a radionuclide, the integrity of the lung's vascular system can then be imaged using the Gamma Cameras which are typically available in all hospitals with a Nuclear Medicine department.

It is important for diagnostic image quality that the PulmoBind molecule is only retained in the lungs, and we are very pleased to announce that in- vivo studies have shown that the molecule is predominantly retained in the lungs 30 minutes after injection with only minor retention (~ 1/10th) in the liver and heart. It is equally important that after imaging the molecule is quickly eliminated from the body and further bio-distribution studies have show that after 240 minutes the majority of the injected molecules have been eliminated through the kidneys and bladder.

About Pulmo BioTech Inc.

Pulmo BioTech Inc. specializes in the development and marketing of medical technology and research. Our proven strengths combine extensive commercial experience and academic credentials. The principal staff members are acknowledged experts in their specialized fields, and work with a broad range of investment institutions. Our mission is to utilize scientific imagination and drive, together with managerial and financial acumen, to bring innovative and profitable products to the marketplace to the benefit of all stock holders.

About PulmoScience Inc.

PulmoScience Inc. was esta
'/>"/>

SOURCE Pulmo BioTech Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related medicine technology :

1. Tracleer(R) Shows Clinical Benefit as Combination Therapy with Sildenafil for Pulmonary Arterial Hypertension
2. Results of TRIUMPH-1 Trial of Viveta in Pulmonary Arterial Hypertension to Be Announced Before Market Open on Thursday, November 1, 2007
3. Study Shows Need to Test More COPD and Asthma Patients for Underdiagnosed Pulmonary Disease
4. Pediatric Pulmonary Expert Comments on Study of Lung Transplants for Cystic Fibrosis
5. Edwards Lifesciences Announces First Implants in U.S. Study of Minimally-Invasive Pulmonic Valve
6. PulmoBioTech Announces Details of Its Regulatory Approval Experiments
7. Terguride Receives FDA Orphan Drug Designation for the Treatment of Pulmonary Arterial Hypertension
8. Pulmo BioTech Announces Details of the Methodology for its Phase I Human Trials
9. Pivotal Pulmonary Arterial Hypertension Study Published in The Lancet Concludes That Bosentan (Tracleer(R)) Demonstrates Benefits in Patients With Mildly Symptomatic WHO Functional Class II Disease
10. Positive Mid-Term Results on CryoValve(R) SG Pulmonary Human Heart Valve Presented at Western Thoracic Meeting
11. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... , 21. Mai 2013 ... die die Firmen OMNIlife science® Inc., Enztec Ltd. ... hat zwei neue, erfahrene Mitglieder in die ... , eine erfahrene Führungspersönlichkeit aus der Orthopädie, ... David Johnson , anerkannter Experte ...
(Date:5/21/2013)... mayo de 2013 La junta directiva ... incluyen OMNIlife science®, Inc., Enztec, Ltd. y Praxim, SA, ... junta. Guy Mayer, un ejecutivo ortopédico experimentado, será vicepresidente ... Johnson , un experto refutado en dispositivos ... de unirse a OSI como presidente de la ...
(Date:5/21/2013)... Calif. , May 21, 2013 RenovoRx ... prestigious 2013 TiE50 "Top Startup" Award at TiEcon 2013, ... innovation, strong management team and quality of entrepreneurial ideas. ... at the Santa Clara Convention ... highly influential list of the most enterprising startup companies ...
Breaking Medicine Technology:Orthopaedic Synergy Inc. meldet bedeutenden Zuwachs im Vorstand 2Orthopaedic Synergy Inc. meldet bedeutenden Zuwachs im Vorstand 3Orthopaedic Synergy, Inc. anuncia nuevas incorporaciones a la junta directiva 2Orthopaedic Synergy, Inc. anuncia nuevas incorporaciones a la junta directiva 3RenovoRx Named Winner of 2013 TiE50 "Top Startup" 2
... Arbor Pharmaceuticals announced today that it has filed ... Food and Drug Administration (FDA).  The recently filed product ... which provides seven years of market exclusivity. In addition, ... this product primarily due to the safety advantages it ...
... MADISON, Wis., Dec. 1, 2011 Novelos Therapeutics, Inc. ... treatment and diagnosis of cancer, today announced the pricing of ... unit for gross proceeds of $5,904,000.  Each unit consists of ... one share of common stock.  The warrants will have an ...
Cached Medicine Technology:Arbor Pharmaceuticals Announces Filing of First NDA 2Novelos Therapeutics Prices $5.9 Million Public Offering 2
(Date:5/21/2013)... Calabash, NC (PRWEB) May 21, 2013 ... Lodges is synonymous with comprehensive travel guides. Brunswick Plantation ... play golf packages that include access to 27 holes ... available golf courses in North Carolina, knowing the ... Resorts and Lodges takes away the overwhelming task of ...
(Date:5/21/2013)... (PRWEB) May 22, 2013 About one ... the Fertility Clinics industry one of the ... assists patients who are unable to conceive naturally through ... popular of which is in-vitro fertilisation (IVF) cycles. Over ... cycles in Australia has increased by 4.4% per annum ...
(Date:5/21/2013)... Steven Reinberg HealthDay Reporter , , TUESDAY, May ... a major cause of sleep apnea in children, and ... learning for these kids, it did help them with ... finds. Sleep apnea is a condition that causes ... a greater improvement in sleep with the surgery, and ...
(Date:5/21/2013)... University of Iowa,s vice president for research and ... exascale computing, the next generation of supercomputers designed ... to the human mind. , Daniel Reed will ... of the House Subcommittee on Energy, titled, "America,s ... begins at 10 a.m. in Room 2318 of ...
(Date:5/21/2013)... Norton HealthDay Reporter , , TUESDAY, May 21 ... two genes may be at increased risk of suffering ... The researchers hope they can use the findings ... pregnant women who are vulnerable to postpartum depression, which ... study, reported in the May 21 issue of the ...
Breaking Medicine News(10 mins):Health News:Brunswick Plantation & Golf Resort Named in Top 10 Golf Resorts in North Carolina 2Health News:Fertility Clinics in Australia Industry Market Research Report Now Available from IBISWorld 2Health News:Fertility Clinics in Australia Industry Market Research Report Now Available from IBISWorld 3Health News:Removing Tonsils Helps Kids With Sleep Apnea, Study Finds 2Health News:Removing Tonsils Helps Kids With Sleep Apnea, Study Finds 3Health News:Iowa VP for Research addresses next-generation supercomputers at congressional hearing 2Health News:Genes May Boost Woman's Risk of Postpartum Depression 2Health News:Genes May Boost Woman's Risk of Postpartum Depression 3
... FUND RESEARCH TO CURE CANCER IN ... DOGS - RESEARCH ALSO BENEFITING HUMANS, DENVER, Jan. 18 ... dogs and or very special humans in your life.,Morris Animal Foundation ... contributing $50 or more to the MAF canine,cancer cure research effort. ...
... LifeSync Corporation is,pleased to announce the appointment of ... McLane comes to LifeSync Corporation after,seven years at ... she,most recently held the position of Executive Director ... McLane spent over 13,years at C.R. Bard in ...
... by Christian Rocker and Top ,Clean, Comedian Round Out the All-Star ... ... 18 Our Savior Lutheran Church,announced today an all-star line-up for its ... Sure to satisfy all in,attendance, LoveFest offers its most diverse casting to ...
... dual implantation of radioactive seeds and chemotherapy wafers ... led by specialists at the Neuroscience Institute at ... , The study, published in the February issue ... treated with simultaneous implantation of radioactive seeds and ...
... are aimed at getting action from Cardinal George and Public Official ... ... 17 Three years ago, health care activist,Joe Novak -- during a ... end the abuses of not-for-profit health,care systems, especially those that are Catholic., ...
... Medical,Center has held extensive settlement discussions with the Public ... their apparent negotiating,tactic we remain optimistic that these discussions ... The filing of a lawsuit was unnecessary given the ... not receive any document outlining,Mr. Olvera,s specific claims until ...
Cached Medicine News:Health News:Unique Gift for Valentine's Day: Canine Cancer Campaign Customized Dog Tag - for Your Dog or as a Beautiful Piece of Jewelry for a Special Human 2Health News:LifeSync Corporation Appoints Nancy McLane as Senior Vice President Operations 2Health News:LoveFest 6 Taps Hollywood Actress to Headline Annual Abstinence Conference 2Health News:Combined radiation seed, chemotherapy wafer implants show promise in treating cancerous brain tumors 2Health News:Ad Campaign Targets Abuses by Not-For-Profits 2Health News:Hollywood Presbyterian Medical Center Responds to ACLU Lawsuit 2
... The Eppendorf Reference Series 2000 Pipette is ... stroke, a compact and robust design, and ... is used to operate the measuring stroke ... tip. Product features:Eppendorf "pipette/tip" system ensures utmost ...
... The Eppendorf Reference Series 2000 Pipette is ... stroke, a compact and robust design, and ... is used to operate the measuring stroke ... tip. Product features:Eppendorf "pipette/tip" system ensures utmost ...
Inquire...
... The Eppendorf Reference Series 2000 Pipette ... smooth stroke, a compact and robust design, ... button is used to operate the measuring ... the tip. Product features:Eppendorf "pipette/tip" system ensures ...
Medicine Products: